These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16801607)

  • 1. Glucose variability and complications.
    Bolli GB
    Diabetes Care; 2006 Jul; 29(7):1707-9. PubMed ID: 16801607
    [No Abstract]   [Full Text] [Related]  

  • 2. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The problem of the complications of diabetes].
    Ward JD
    Journ Annu Diabetol Hotel Dieu; 1984; ():321-5. PubMed ID: 6537447
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathogenesis of late diabetic damage].
    Sailer S; Zeichen R
    Wien Med Wochenschr; 1985 Apr; 135(6-7):177-80. PubMed ID: 4002727
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycemic variability in the development of cardiovascular complications in diabetes.
    Nusca A; Tuccinardi D; Albano M; Cavallaro C; Ricottini E; Manfrini S; Pozzilli P; Di Sciascio G
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3047. PubMed ID: 30028067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
    Maahs DM
    Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
    Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
    J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood glucose control and microvascular and macrovascular complications in diabetes.
    Hanssen KF
    Diabetes; 1997 Sep; 46 Suppl 2():S101-3. PubMed ID: 9285509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the estimated glucose disposal rate as a marker of microvascular complications in young adults with type 1 diabetes.
    Girgis CM; Scalley BD; Park KE
    Diabetes Res Clin Pract; 2012 Jun; 96(3):e70-2. PubMed ID: 22385830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The study of development and progression of long-term complications in type I diabetes].
    Araki E; Matsumura T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
    [No Abstract]   [Full Text] [Related]  

  • 12. The science of hypoglycemia in patients with diabetes.
    Oyer DS
    Curr Diabetes Rev; 2013 May; 9(3):195-208. PubMed ID: 23506375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
    Šoupal J; Škrha J; Fajmon M; Horová E; Mráz M; Škrha J; Prázný M
    Diabetes Technol Ther; 2014 Apr; 16(4):198-203. PubMed ID: 24401008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular disease in diabetes mellitus.
    Kollros PR; Konkle BA
    Coron Artery Dis; 1996 Oct; 7(10):702-7. PubMed ID: 8970760
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Monnier L; Colette C; Leiter L; Ceriello A; Hanefeld M; Owens D; Tajima N; Tuomiletho J; Davidson J;
    Diabetes Care; 2007 Jan; 30(1):185-6; author reply 187-8. PubMed ID: 17192363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glycosylated blood proteins in diabetes mellitus].
    Germaniuk IaL
    Klin Med (Mosk); 1982 Oct; 60(10):17-21. PubMed ID: 6757559
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability.
    Zaccardi F; Pitocco D; Ghirlanda G
    Diabetes Metab Res Rev; 2009 Mar; 25(3):199-207. PubMed ID: 19172575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile-onset diabetes mellitus. Glucose control and microvascular changes.
    Mueller SM; Latimer DM; Mick MJ
    Indiana Med; 1986 Feb; 79(2):159-64. PubMed ID: 3950377
    [No Abstract]   [Full Text] [Related]  

  • 19. Tight control of blood glucose in long standing type 2 diabetes.
    Lehman R; Krumholz HM
    BMJ; 2009 Mar; 338():b800. PubMed ID: 19264821
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
    Hirsch IB; Brownlee M
    Diabetes Care; 2007 Jan; 30(1):186-7; author reply 188-9. PubMed ID: 17192365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.